profit from every $100 of sales.
$0$100
NeuroOne Medical Technologies
$0.80+3.26% today
-81.7% in 1 year
1-year low $0.781-year high $5.89
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What NeuroOne Medical Technologies sold, what it kept, and what it did with the cash.
Sales went from $171,169 in 2022 to $9.10 million in 2025, with -$3.61 million of profit last year.
SalesProfit
NeuroOne Medical Technologies vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| NeuroOne Medical Technologies | No profit yet | ||
 Boston Scientific | 22.6× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.8× · Expensive | ||
 Zimmer Biomet Holdings | 28.8× · Fair price |
AI analysis
An AI analyst reads NeuroOne Medical Technologies's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 2 | 3 | 9 | |
| -0 | 0 | 1 | 5 | |
| -10 | -12 | -12 | -4 | |
| -10 | -12 | -12 | -3 | |
| -10 | -12 | -12 | -4 | |
| -3.78 | -3.90 | -2.76 | -0.54 | |
| -41.4% | 23.4% | 31.3% | 56.5% | |
| -5,860.2% | -612.3% | -344.3% | -46.5% | |
| -5,842.0% | -607.4% | -356.7% | -39.6% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 13 | 8 | 5 | 11 |
| Cash | 8 | 5 | 1 | 7 |
| Total debt | 0 | 0 | 0 | 0 |
| Total liabilities | 3 | 2 | 5 | 4 |
| 10 | 6 | 1 | 7 | |
| 3 | 3 | 4 | 7 | |
| -80.8% | -145.6% | -882.5% | -35.2% | |
| -104.1% | -189.8% | -1,498.5% | -51.0% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -8 | -13 | -11 | -3 | |
| 0 | 0 | 0 | 0 | |
| -8 | -13 | -11 | -3 | |
| Dividends paid | – | – | – | – |
| 0 | 0 | 0 | 0 | |
| 1 | 1 | 1 | 1 |
Valuation
- –
- –
- –
- 5.8×
- 0.8×
- –
- –
- -40.0%
- -49.3%
- 0.0%
Profitability
- 56.5%
- -46.5%
- -39.6%
- -68.5%
- -112.3%
- -323.7%
- -98.3%
- -84.5%
- -114.4%
- 53.1%
Growth
- +276.0%
- –
- +73.8%
- –
- +39.2%
Financial health
- -2.1×
- 0.04
- 2.6%
- 21.8×
- 4.37
- 3.26
- 1.24
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 7%of 889
Top 1%of 890
Bottom 1%of 987
What analysts expect
- Average price target
- $3.00
- Range
- $3.00 – $3.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 12, 2026 | -0.25 | -0.23 | −10.3% |
| Feb 17, 2026 | -0.18 | -0.24 | +25.0% |
| Dec 17, 2025 | -0.05 | -0.04 | −25.0% |
| Aug 14, 2025 | -0.03 | -0.05 | +40.0% |
| May 13, 2025 | -0.07 | -0.09 | +22.2% |
| Feb 12, 2025 | 0.06 | -0.10 | +160.0% |
| Dec 17, 2024 | -0.11 | -0.09 | −22.2% |
| Aug 14, 2024 | -0.10 | -0.09 | −11.1% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
44No pass
Benjamin Graham
40No pass
Philip Fisher
43No pass
Peter Lynch
49No pass
Joel Greenblatt
0No pass
Charlie Munger
35No pass
Terry Smith
32No pass
Questions about NeuroOne Medical Technologies
Is NeuroOne Medical Technologies a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the NeuroOne Medical Technologies AI analysis
What does NeuroOne Medical Technologies do?
NeuroOne Medical Technologies Corporation operates as a medical technology company. It is in Medical - Devices.
Does NeuroOne Medical Technologies pay a dividend?
No. NeuroOne Medical Technologies does not pay a dividend at the moment; in 2025 it returned $124,617 to shareholders by buying back its own shares.
Is NeuroOne Medical Technologies stock halal?
No. NeuroOne Medical Technologies does not pass our halal screen: its cash and confirmed interest-bearing investments are 90% of its market value, at or above the 33% limit. How we check
How has NeuroOne Medical Technologies stock done over the past year?
Down 81.7% over the past twelve months, to $0.80. It traded between $0.78 and $5.89 and is 86.4% below its high.
Who are NeuroOne Medical Technologies's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with NeuroOne Medical Technologies's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.